188 related articles for article (PubMed ID: 35714161)
1. Risk factors for Fontan-associated hepatocellular carcinoma.
Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive biomarkers of Fontan-associated liver disease.
Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
[TBL] [Abstract][Full Text] [Related]
4. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
[TBL] [Abstract][Full Text] [Related]
5. The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.
Sakamori R; Yamada R; Tahata Y; Kodama T; Hikita H; Tatsumi T; Yamada T; Takehara T
J Gastroenterol; 2022 Feb; 57(2):111-119. PubMed ID: 35064829
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.
Onishi H; Toh N; Akagi T; Baba K; Kotani Y; Takaki A; Kasahara S; Ito H
Clin J Gastroenterol; 2024 Feb; 17(1):148-154. PubMed ID: 38032452
[TBL] [Abstract][Full Text] [Related]
7. Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma.
Lee YR; Park SY; Tak WY
Gut Liver; 2020 Jul; 14(4):500-508. PubMed ID: 31816673
[TBL] [Abstract][Full Text] [Related]
8. Fontan Hepatopathy-Managing Unknowns.
Zentner D; Phan K; Gorelik A; Keung C; Grigg L; Sood S; Gibson R; Nicoll AJ
Heart Lung Circ; 2023 Apr; 32(4):535-543. PubMed ID: 36642589
[TBL] [Abstract][Full Text] [Related]
9. Fontan-associated liver disease and hepatocellular carcinoma in adults.
Kogiso T; Tokushige K
Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
[TBL] [Abstract][Full Text] [Related]
10. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
[TBL] [Abstract][Full Text] [Related]
12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
13. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
[TBL] [Abstract][Full Text] [Related]
14. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.
Guerrini GP; Pinelli D; Marini E; Corno V; Guizzetti M; Zambelli M; Aluffi A; Lincini L; Fagiuoli S; Lucianetti A; Colledan M
Prog Transplant; 2018 Mar; 28(1):63-69. PubMed ID: 29251164
[TBL] [Abstract][Full Text] [Related]
15. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
[TBL] [Abstract][Full Text] [Related]
16. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
[TBL] [Abstract][Full Text] [Related]
17. Fontan-associated liver disease: A review.
Gordon-Walker TT; Bove K; Veldtman G
J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
[TBL] [Abstract][Full Text] [Related]
18. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure.
Rodriguez DS; Mao C; Mahle WT; Kanter KR; Alazraki A; Braithwaite K; Rytting H; Caltharp S; Magliocca JF; Romero R
J Pediatr; 2021 Feb; 229():78-85.e2. PubMed ID: 32976893
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
[TBL] [Abstract][Full Text] [Related]
20. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score.
Hsu KY; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
World J Surg; 2009 Nov; 33(11):2412-9. PubMed ID: 19756859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
